San Diego, CA, United States of America

Stephen P Govek

This inventor holds 1 USPTO granted patent. Top assignee: Metacrine, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen P Govek. Retrieved from https://idiyas.com/inventor/stephen-p-govek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen P. Govek

Introduction

Stephen P. Govek is an accomplished inventor based in San Diego, California. He is known for his significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target the farnesoid X receptor. His work has implications for treating various conditions associated with this receptor's activity.

Latest Patents

Stephen P. Govek holds a patent for "Farnesoid X receptor agonists and uses thereof." This patent describes compounds that act as farnesoid X receptor agonists, along with methods for making these compounds. It also includes pharmaceutical compositions and medicaments that incorporate these compounds, as well as methods for using them in the treatment of conditions, diseases, or disorders linked to farnesoid X receptor activity. He has 1 patent to his name.

Career Highlights

Stephen is currently employed at Metacrine, Inc., where he continues to innovate in the field of drug development. His work at Metacrine focuses on advancing therapeutic options that leverage the farnesoid X receptor pathway.

Collaborations

Stephen has collaborated with notable colleagues, including Nicholas D. Smith and Johnny Yasuo Nagasawa. These partnerships have contributed to the advancement of research and development in their shared field of expertise.

Conclusion

Stephen P. Govek's contributions to the field of pharmaceutical sciences highlight his innovative spirit and dedication to improving health outcomes. His work on farnesoid X receptor agonists represents a significant advancement in the treatment of related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…